245 related articles for article (PubMed ID: 29890069)
1. New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii.
Minrovic BM; Jung D; Melander RJ; Melander C
ACS Infect Dis; 2018 Sep; 4(9):1368-1376. PubMed ID: 29890069
[TBL] [Abstract][Full Text] [Related]
2. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
[TBL] [Abstract][Full Text] [Related]
3. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
[TBL] [Abstract][Full Text] [Related]
4. Colistin-phage combinations decrease antibiotic resistance in
Wang X; Loh B; Gordillo Altamirano F; Yu Y; Hua X; Leptihn S
Emerg Microbes Infect; 2021 Dec; 10(1):2205-2219. PubMed ID: 34736365
[TBL] [Abstract][Full Text] [Related]
5. Structure-Function Studies on IMD-0354 Identifies Highly Active Colistin Adjuvants.
Nemeth AM; Basak AK; Weig AW; Marrujo SA; Barker WT; Jania LA; Hendricks TA; Sullivan AE; O'Connor PM; Melander RJ; Koller BH; Melander C
ChemMedChem; 2020 Jan; 15(2):210-218. PubMed ID: 31756025
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Khalil MAF; Moawad SS; Hefzy EM
J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.
Antunes LC; Imperi F; Minandri F; Visca P
Antimicrob Agents Chemother; 2012 Nov; 56(11):5961-70. PubMed ID: 22964249
[TBL] [Abstract][Full Text] [Related]
8. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
10. Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants.
Siwawannapong K; Nemeth AM; Melander RJ; Rong J; Davis JR; Taniguchi M; Carpenter ME; Lindsey JS; Melander C
ChemMedChem; 2022 Aug; 17(16):e202200286. PubMed ID: 35704751
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.
Hornsey M; Wareham DW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3534-7. PubMed ID: 21502628
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
13. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
Wei W; Yang H; Hu L; Ye Y; Li J
J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
[TBL] [Abstract][Full Text] [Related]
14. Colistin Dependence in Extensively Drug-Resistant
Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
[TBL] [Abstract][Full Text] [Related]
16. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
17. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.
Napier BA; Burd EM; Satola SW; Cagle SM; Ray SM; McGann P; Pohl J; Lesho EP; Weiss DS
mBio; 2013 May; 4(3):e00021-13. PubMed ID: 23695834
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]